Clinical Research Directory
Browse clinical research sites, groups, and studies.
High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
Sponsor: University of Florida
Summary
A 12-week double-blind randomized control trial will be conducted among adults on hemodialysis (n=15) to determine the impact of liposomal curcumin in a high-protein product on inflammation markers and oxidative stress. Participants will be randomized via a computer-generator into either the control or intervention group. Participants in each group will be given a total of 38 g of a high protein product with or without 7 mls of liposomal curcumin for a total of 8 weeks. At baseline, weeks 8 and 12, participants will have blood sampled and complete a 3-day 24-hour recalls (2 non-dialysis days and 1 dialysis day) and a quality of life survey.
Official title: Examining the Impact of High-protein Oral Supplement With Liposomal Curcumin on Inflammation Markers and Oxidative Stress in Adults Undergoing Hemodialysis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
39
Start Date
2025-02-03
Completion Date
2025-05-13
Last Updated
2026-06-01
Healthy Volunteers
No
Conditions
Interventions
Liposomal curcumin
participants will consume the product ad libitum for the 24 treatments.
Food colorant
participants will consume the product ad libitum for the 24 treatments as a placebo.
Locations (1)
University of Florida
Gainesville, Florida, United States